or Try an Advanced Search...

    Technical Analysis for SAVA - Cassava Sciences, Inc.

    Grade Last Price % Change Price Change
    F 16.64 -1.30% -0.22
    SAVA closed down 1.3 percent on Friday, September 29, 2023, on 87 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    7 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical SAVA trend table...
    Date Alert Name Type % Chg
    New 52 Week Closing Low Bearish 0.00%
    Wide Bands Range Expansion 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Doji - Bullish? Reversal -1.30%
    Wide Bands Range Expansion -1.30%
    Down 3 Days in a Row Weakness -1.30%
    Oversold Stochastic Weakness -1.30%
    Stochastic Buy Signal Bullish -1.83%
    Older End-of-Day Signals for SAVA ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    Fell Below Previous Day's Low about 12 hours ago
    Down 1% about 12 hours ago
    60 Minute Opening Range Breakdown about 12 hours ago
    Up 1% about 14 hours ago
    60 Minute Opening Range Breakout 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    SAVA Chart by TradingView
    Basic chart:

    Profile

    Cassava Sciences, Inc. develops drugs for nervous system disorders in the United States. It engages in developing FENROCK, a proprietary abuse-deterrent transdermal pain patch for pain relief; PTI-125, a small molecule drug candidate to treat Alzheimer's disease; and PTI-125DX, a blood-based diagnostic/biomarker to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. Cassava Sciences, Inc. was founded in 1998 and is based in Austin, Texas.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biology Pain Neuroscience Alzheimer's Disease Mental Health Biomarkers Nervous System Disorders Psychiatric Diagnosis Psychiatry Transdermal Abnormal Psychology

    Is SAVA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Sep 18 Cassava's simufilam for Alzheimer's gets safety clearance in phase 3
    Sep 18 Cassava Sciences Announces Positive Interim Safety Review of Simufilam On-going Phase 3 Trials in Patients with Alzheimer’s Disease
    Sep 14 Alzheimer's drug developers get lift from Anavex results
    Sep 14 The 7 Best Meme Stocks to Buy Now: September 2023
    Sep 12 Jim Cramer Says No To This Fintech Titan With Declining Margins: 'I Think It's A Value Trap'
    Sep 11 Cassava Sciences Announces Science Publication That Confirms Mechanism of Action of Simufilam, a Novel Drug Candidate for People with Alzheimer’s Disease
    Sep 6 Cassava Sciences Invited to Present in Four Upcoming Investor Conferences
    Aug 29 16 Most Shorted Stocks Right Now
    Aug 25 Cassava Sciences: Insiders Purchasing Stock, Is The Market Still Buying Simufilam?
    Aug 25 Biggest stock movers today: Hawaiian Electric, Affirm Holdings and more
    See more SAVA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 46.29
    52 Week Low 16.55
    Average Volume 838,119
    200-Day Moving Average 24.59
    50-Day Moving Average 19.21
    20-Day Moving Average 18.96
    10-Day Moving Average 17.56
    Average True Range 0.93
    RSI (14) 31.51
    ADX 18.2
    +DI 18.11
    -DI 29.89
    Chandelier Exit (Long, 3 ATRs) 19.77
    Chandelier Exit (Short, 3 ATRs) 19.35
    Upper Bollinger Bands 22.08
    Lower Bollinger Band 15.85
    Percent B (%b) 0.13
    BandWidth 32.89
    MACD Line -0.79
    MACD Signal Line -0.52
    MACD Histogram -0.2625
    Fundamentals Value
    Market Cap 581.63 Million
    Num Shares 35 Million
    EPS -0.27
    Price-to-Earnings (P/E) Ratio -60.73
    Price-to-Sales 0.00
    Price-to-Book 11.31
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 17.46
    Resistance 3 (R3) 17.52 17.31 17.32
    Resistance 2 (R2) 17.31 17.10 17.28 17.27
    Resistance 1 (R1) 16.98 16.98 16.87 16.91 17.23
    Pivot Point 16.77 16.77 16.72 16.74 16.77
    Support 1 (S1) 16.43 16.56 16.33 16.37 16.05
    Support 2 (S2) 16.22 16.43 16.19 16.01
    Support 3 (S3) 15.89 16.22 15.96
    Support 4 (S4) 15.82